MYELOPROLIFERATIVE DISORDERS
Clinical trials for MYELOPROLIFERATIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE DISORDERS trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for rare blood cancers
Disease control CompletedThis study tested a new pill called pelabresib in people with certain blood cancers, including myelofibrosis and leukemia. The goal was to see if it could shrink enlarged spleens and reduce the need for blood transfusions. The drug was given alone or with another medicine (ruxoli…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
650 blood cancer patients help scientists predict disease outcomes
Knowledge-focused CompletedThis study looked at 650 adults with acute leukemia, myelodysplastic syndromes, or myeloproliferative disorders. Researchers collected blood, bone marrow, skin, and cheek cell samples to find genetic and other markers that could predict how the disease behaves. The goal was to be…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC